Honolulu Star-Advertiser

Saturday, December 14, 2024 77° Today's Paper


Top News

4th death, more vision loss cases linked to tainted eyedrops

JANICE HANEY CARR/CDC VIA AP
                                This scanning electron microscope image made available by the Centers for Disease Control and Prevention shows rod-shaped Pseudomonas aeruginosa bacteria. On Friday, May 19, the U.S. Centers for Disease Control and Prevention reported another death and several more cases of vision loss from illnesses linked to eyedrops tainted with drug-resistant bacteria.

JANICE HANEY CARR/CDC VIA AP

This scanning electron microscope image made available by the Centers for Disease Control and Prevention shows rod-shaped Pseudomonas aeruginosa bacteria. On Friday, May 19, the U.S. Centers for Disease Control and Prevention reported another death and several more cases of vision loss from illnesses linked to eyedrops tainted with drug-resistant bacteria.

NEW YORK >> U.S. health officials reported another death and several more cases of vision loss from illnesses linked to eyedrops tainted with a drug-resistant bacteria.

The bacteria has infected 81 people, including four who died and 14 who lost vision, the Centers for Disease Control and Prevention said Friday. That’s up from three deaths and eight cases of vision loss reported in March. The CDC also said four people have undergone surgery to remove an eyeball due to the infections.

The outbreak is considered particularly worrisome because the bacteria driving it — Pseudomonas aeruginosa — is resistant to standard antibiotics.

Investigators say most of the patients had used certain brands of eyedrops, and products from EzriCare and Delsam Pharma were recalled in February. At least seven patients were diagnosed after the recall.

After the recall, U.S. health inspectors visited the plant in India that made the eyedrops and uncovered problems with how the drops were made and tested, including inadequate sterility measures.

Cases have been reported from 18 states — California, Colorado, Connecticut, Delaware, Florida, Illinois, North Carolina, New Jersey, New Mexico, Nevada, New York, Ohio, Pennsylvania, South Dakota, Texas, Utah, Washington and Wisconsin.

By participating in online discussions you acknowledge that you have agreed to the Terms of Service. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. Report comments if you believe they do not follow our guidelines. Having trouble with comments? Learn more here.